Abbott | ABT - Ebitda





Ebitda Alterar Data
Abbott USD 2.43B 844M 2026-03
Agilent USD 456M 84M 2025-12
AtriCure USD 17.07M 2.79M 2026-03
Baxter International USD -447M 873M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio-Rad Laboratories USD 983.8M 1.36B 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Danaher USD 1.92B 204M 2026-03
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Globus Medical USD 280.46M 27.86M 2025-12
Insulet USD 181.7M 12.3M 2026-03
Integra LifeSciences USD 76.18M 28.03M 2026-03
Intuitive Surgical USD 1.06B 29.9M 2026-03
J&J USD 8.27B 1.08B 2026-03
Medtronic USD 2.81B 119M 2026-03
Merit Medical Systems USD 97.23M 17.69M 2025-12
Pfizer USD 5.99B 5.23B 2026-03
Smith & Nephew USD 796M 139M 2025-12
Solventum Corp USD 437M 0 2026-03
Stryker USD 1.57B 618M 2026-03
Tandem Diabetes Care USD 2.73M 30.17M 2026-03
Teleflex USD 247.07M 575.88M 2025-12
Terumo JPY 57.88B 12.1B 2026-03
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Zimmer Biomet Holdings USD 759M 120.8M 2025-12